Your Sorted CME/CE Activities

Conversations in HCV: Evolving Treatment Options
Certified CME/CNE/CPE Activity
New pan-genotypic regimens continue to transform HCV management with more potent, more convenient, and safer regimens. These rapid changes require clinicians to become continually educated on the state-of-the-art approach to HCV management as well as safe and appropriate use of these newer regimens.

These Conversations in HCV will discuss the use of 8- or 12-week HCV regimens in treatment-naïve patients, HCV management issue in contemporary difficult-to-cure patients, and considerations in the setting of renal disease, HCC, and transplantation.
Review each video to claim AMA, ANCC, or ACPE credit/contact hour(s) after completion of the brief Post-Test/Evaluation.





Robert S. Brown, Jr., MD, MPH Robert S. Brown, Jr., MD, MPH
Gladys and Roland Harriman
Professor of Medicine
Clinical Chief, Division of Gastroenterology & Hepatology
Weill Cornell Medical College
Director, Center for Liver Disease and Transplantation
New York-Presbyterian Hospital
David Nelson, MD David Nelson, MD
Professor of Medicine and
Assistant Vice President for Research
University of Florida
       
Nancy Reau, MD, FAASLD, AGAF Nancy Reau, MD, FAASLD, AGAF
Section Chief, Hepatology
Rush University Medical Center
Associate Director, Solid Organ Transplantation
Rush University Medical Center
   

20
Supported by an independent educational grant from AbbVie and Gilead Sciences Medical Affairs
Expired Activity
Clinical Conversation
6171
ConversationsInHCV.v2_WebBanner(1).gif
LiverDisease